Among the known substrates of SIRT7 are PAF53, NPM1, GABP-β1, but more importantly, SIRT7 catalyzes the deacetylation of lysine 18 on histone H3 (H3K18), a marker of cancer aggressiveness and poor prognosis [9]. Here, SIRT7 is linked to cancer.